4
MARKET OVERVIEW
Lipid nanoparticles revolutionize anti-cancer therapies amid regulatory hurdles and rising R&D investments.
48
4.2.1.1
INCREASING USE OF LIPID NANOPARTICLES IN ANTI-CANCER THERAPIES
4.2.1.2
HIGH UPTAKE IN RNA-BASED THERAPEUTIC RESEARCH
4.2.1.3
GROWING GOVERNMENT FOCUS ON R&D FOR LNP-BASED DRUGS
4.2.2.1
STRINGENT REGULATORY REQUIREMENTS
4.2.3.1
GROWING DEMAND FOR ADVANCED DRUG DELIVERY SYSTEMS
4.2.4.1
CHALLENGES ASSOCIATED WITH LNP FORMULATION
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and economic shifts to leverage industry growth and pricing strategies.
55
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS & FORECAST
5.2.3
GDP TRENDS & FORECAST
5.5.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025
5.5.2
AVERAGE SELLING PRICE TREND, BY TYPE (2023–2025)
5.6
KEY CONFERENCES & EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.8
INVESTMENT & FUNDING SCENARIO
5.9
IMPACT OF 2025 US TARIFFS—LIPID NANOPARTICLES MARKET
5.9.2
PRICE IMPACT ANALYSIS
5.9.3
IMPACT ON COUNTRIES/REGIONS
5.9.4
IMPACT ON END-USER INDUSTRIES
5.9.4.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.9.4.3
ACADEMIC & RESEARCH INSTITUTES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI and nanotechnology converge to revolutionize drug delivery and reshape future pharmaceutical landscapes.
72
6.1.1
KEY EMERGING TECHNOLOGIES
6.1.1.1
NANOTECHNOLOGY-BASED DRUG DELIVERY
6.1.1.2
NUCLEIC ACID DELIVERY
6.1.2
COMPLEMENTARY TECHNOLOGIES
6.1.2.1
DRUG ENCAPSULATION TECHNIQUES
6.1.2.2
SURFACE MODIFICATION AND FUNCTIONALIZATION TECHNOLOGIES
6.1.3
ADJACENT TECHNOLOGIES
6.1.3.1
BIOTECHNOLOGY & GENETIC ENGINEERING TECHNOLOGIES
6.1.3.2
NANOTECHNOLOGY-BASED FORMULATION TECHNIQUES
6.2
TECHNOLOGY/PRODUCT ROADMAP
6.3.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR LIPID NANOPARTICLE PATENTS, 2015–2025
6.5
IMPACT OF GENERATIVE AI ON LIPID NANOPARTICLES MARKET
6.5.1
BEST PRACTICES IN LIPID NANOPARTICLE WORKFLOWS
6.5.2
CASE STUDIES OF AI IMPLEMENTATION
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex global regulations to align sustainability initiatives with industry standards and eco-certifications.
82
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY SCENARIO
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Uncover how stakeholder influence shapes buying criteria and profitability in lipid nanoparticle markets.
90
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA FOR LIPID NANOPARTICLE RAW MATERIALS, BY END USER
8.2.3
KEY BUYING CRITERIA FOR LIPID NANOPARTICLE SERVICES, BY END USER
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
LNP RAW MATERIALS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
96
9.2.1
HIGH DEMAND FOR MRNA-BASED VACCINES TO PROPEL MARKET
9.3.1
GROWING FOCUS ON NUCLEIC ACID MEDICINES TO BOOST DEMAND
9.4.1
ENHANCED STABILITY AND HIGH UPTAKE IN THERAPEUTIC APPLICATIONS TO DRIVE MARKET
9.5.1
BIOLOGICAL COMPATIBILITY AND CUSTOMIZATION FEATURES TO SUPPORT MARKET GROWTH
9.6.1
ADVANCEMENTS IN LNP FORMULATION TECHNIQUES TO DRIVE MARKET
9.7
OTHER FORMULATION MATERIALS
10
LNP RAW MATERIALS MARKET, BY LNP TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 19 Data Tables
108
10.2
SOLID LIPID NANOPARTICLES (SLNS)
10.2.1
ADVANTAGES OVER CONVENTIONAL DRUG CARRIERS TO DRIVE MARKET
10.3
NANOSTRUCTURED LIPID CARRIERS (NLCS)
10.3.1
HIGH DRUG LOADING CAPACITY TO PROPEL MARKET
11
LNP RAW MATERIALS MARKET, BY MOLECULE TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 19 Data Tables
117
11.2.1
GROWING FOCUS ON TARGETED DRUG DELIVERY TO DRIVE MARKET
11.3.1
GROWING UPTAKE IN VACCINE DEVELOPMENT TO PROPEL MARKET
12
LNP RAW MATERIALS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 45 Data Tables
127
12.2
COMMERCIAL APPLICATIONS
12.2.1.1
ABILITY TO PROVIDE TARGETED & SUSTAINED RELEASE OF THERAPEUTIC AGENTS TO BOOST DEMAND
12.2.2
OTHER COMMERCIAL APPLICATIONS
12.3
CLINICAL APPLICATIONS
12.3.1.1
THREAT OF EVOLVING EMERGING VARIANTS TO FUEL UPTAKE
12.3.2.1
INCREASING FOCUS ON ONCOLOGY THERAPEUTICS TO DRIVE MARKET
12.3.3
OTHER CLINICAL APPLICATIONS
13
LNP RAW MATERIALS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 19 Data Tables
146
13.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.2.1
INCREASING DRUG DEVELOPMENT ACTIVITIES TO FUEL MARKET
13.3
ACADEMIC & RESEARCH INSTITUTES
13.3.1
HIGH FOCUS ON R&D FOR GENE THERAPY AND MEDICATION ADMINISTRATION TO DRIVE MARKET
13.4
CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (CDMOS)
13.4.1
GROWING OUTSOURCING OF LNP FORMULATION SERVICES TO PROPEL MARKET
14
LNP SERVICES MARKET, BY SERVICE TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables
155
14.2
FORMULATION DEVELOPMENT SERVICES
14.2.1
GROWING FOCUS ON TARGETED & EFFECTIVE DRUG DELIVERY TO PROPEL MARKET
14.3
MANUFACTURING SERVICES
14.3.1
RISING DEMAND FOR LIPID-BASED CARRIERS FOR GENE THERAPY AND VACCINE DEVELOPMENT TO DRIVE MARKET
15
LNP SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
160
15.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
15.2.1
DRUG DEVELOPMENT & COMMERCIALIZATION TO PROPEL MARKET
15.3
ACADEMIC & RESEARCH INSTITUTES
15.3.1
ACCESS TO ADVANCED INFRASTRUCTURE AND SPECIALIZED EXPERTISE TO SUPPORT MARKET GROWTH
16
LIPID NANOPARTICLES MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 194 Data Tables.
164
16.2.1.1
HIGH PHARMACEUTICAL R&D EXPENDITURE TO DRIVE MARKET
16.2.2.1
GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
16.3.1.1
RISING DEVELOPMENT ACTIVITIES FOR LNP PRODUCTION TO DRIVE MARKET
16.3.2.1
PIONEERING RESEARCH PROGRAMS FOR DRUG DELIVERY SYSTEMS TO BOOST DEMAND
16.3.3.1
GOVERNMENT FUNDING FOR PROTEOMICS AND GENOMICS RESEARCH TO SUPPORT MARKET GROWTH
16.3.4.1
GROWTH IN LIFE SCIENCES RESEARCH TO PROPEL MARKET
16.3.5.1
GROWING DEMAND FOR CANCER THERAPEUTICS TO DRIVE MARKET
16.4.1.1
LOW MANUFACTURING COSTS AND RISING OUTSOURCING OF SERVICES TO CDMOS TO DRIVE MARKET
16.4.2.1
DEMAND FOR LNP-BASED MRNA VACCINES TO FUEL MARKET
16.4.3.1
GROWTH IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
16.4.4.1
RISING NUMBER OF CLINICAL TRIALS TO BOOST DEMAND
16.4.5.1
GROWING REQUIREMENT FOR INNOVATIVE DRUG DELIVERY SYSTEMS TO PROPEL MARKET
16.4.6
REST OF ASIA PACIFIC
16.5.1.1
GLOBAL MANUFACTURING HUB FOR PHARMACEUTICAL DRUGS TO FUEL UPTAKE
16.5.2.1
LARGE TARGET PATIENT POPULATION AND DEMAND FOR NOVEL DRUG DELIVERY TECHNOLOGY TO DRIVE MARKET
16.5.3
REST OF LATIN AMERICA
16.6.1.1
ECONOMIC & HEALTHCARE EXPANSION TO SUPPORT MARKET GROWTH
16.6.2
REST OF MIDDLE EAST
16.7.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
17
COMPETITIVE LANDSCAPE
Discover strategies and market positions of key players and emerging leaders shaping the competitive landscape.
244
17.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
17.3
REVENUE ANALYSIS 2019–2025
17.4
MARKET SHARE ANALYSIS
17.4.1
LNP RAW MATERIALS MARKET
17.4.2
LNP SERVICES MARKET
17.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
17.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
17.5.5.1
COMPANY FOOTPRINT
17.5.5.2
REGION FOOTPRINT
17.5.5.3
PRODUCT FOOTPRINT
17.5.5.4
APPLICATION FOOTPRINT
17.5.5.5
SERVICE FOOTPRINT
17.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
17.6.1
PROGRESSIVE COMPANIES
17.6.2
RESPONSIVE COMPANIES
17.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
17.7
COMPANY VALUATION & FINANCIAL METRICS
17.8
BRAND/PRODUCT COMPARISON ANALYSIS
17.9
COMPETITIVE SCENARIO
17.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
18
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
266
18.1.1
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC)
18.1.1.1
BUSINESS OVERVIEW
18.1.1.2
PRODUCTS/SERVICES OFFERED
18.1.1.3
RECENT DEVELOPMENTS
18.1.1.3.1
PRODUCT LAUNCHES
18.1.1.3.4
OTHER DEVELOPMENTS
18.1.1.4.2
STRATEGIC CHOICES
18.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
18.1.3
EVONIK INDUSTRIES AG
18.1.4
NIPPON FINE CHEMICAL
18.1.6
FUJIFILM PHARMACEUTICALS U.S.A., INC. (FUJIFILM HOLDINGS CORPORATION)
18.1.7
PRECISION NANOSYSTEMS (CYTIVA)
18.1.14
ACUITAS THERAPEUTICS
18.2.5
MEDKOO BIOSCIENCES, INC.
18.2.8
ASCENDIA PHARMACEUTICALS
18.2.9
CURIA GLOBAL, INC.
18.2.10
VERNAL BIOSCIENCES
19
RESEARCH METHODOLOGY
315
19.2
MARKET ESTIMATION METHODOLOGY
19.2.1
GLOBAL MARKET ESTIMATION
19.2.2
INSIGHTS OF PRIMARY EXPERTS
19.3
MARKET GROWTH RATE PROJECTIONS
19.4
MARKET BREAKDOWN AND DATA TRIANGULATION
19.5
RESEARCH ASSUMPTIONS
19.6
RESEARCH LIMITATIONS
20.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
20.3
CUSTOMIZATION OPTIONS
TABLE 1
LIPID NANOPARTICLES MARKET: IMPACT ANALYSIS
TABLE 2
IMPACT OF PORTER’S FIVE FORCES ON THE LIPID NANOPARTICLES MARKET
TABLE 3
LIPID NANOPARTICLES MARKET: ROLE IN ECOSYSTEM
TABLE 4
AVERAGE SELLING PRICE TREND OF LNP PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)
TABLE 5
AVERAGE SELLING PRICE TREND OF LNP PRODUCTS, BY TYPE, 2023–2025 (USD)
TABLE 6
LIPID NANOPARTICLES MARKET: KEY CONFERENCES & EVENTS (2026–2027)
TABLE 7
LIPID NANOPARTICLE MARKET: INDICATIVE LIST OF PATENTS
TABLE 8
CASE STUDIES OF AI IMPLEMENTATION IN LIPID NANOPARTICLES MARKET
TABLE 9
CLIENTS’ TOP READINESS TO ADOPT GENERATIVE AI IN LIPID NANOPARTICLES MARKET
TABLE 10
REGULATORY SCENARIO
TABLE 11
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
TABLE 17
KEY BUYING CRITERIA FOR LNP RAW MATERIALS, BY END USER
TABLE 18
KEY BUYING CRITERIA FOR LIPID NANOPARTICLE SERVICES, BY END USER
TABLE 19
LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 20
IONIZABLE LIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 21
NORTH AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 22
EUROPE: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 23
ASIA PACIFIC: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 24
LATIN AMERICA: IONIZABLE LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 25
MIDDLE EAST: IONIZABLE LIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 26
PEGYLATED LIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 27
NEUTRAL LIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 28
NORTH AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 29
EUROPE: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 30
ASIA PACIFIC: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 31
LATIN AMERICA: NEUTRAL LIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 32
MIDDLE EAST: NEUTRAL LIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 33
PHOSPHOLIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 34
NORTH AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 35
EUROPE: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 36
ASIA PACIFIC: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 37
LATIN AMERICA: PHOSPHOLIPIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 38
MIDDLE EAST: PHOSPHOLIPIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 39
KITS & REAGENTS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 40
OTHER FORMULATION MATERIALS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 41
LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 42
SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 43
NORTH AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 44
EUROPE: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 45
ASIA PACIFIC: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 46
LATIN AMERICA: SOLID LIPID NANOPARTICLES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 47
MIDDLE EAST: SOLID LIPID NANOPARTICLES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 48
NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 49
NORTH AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 50
EUROPE: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 51
ASIA PACIFIC: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 52
LATIN AMERICA: NANOSTRUCTURED LIPID CARRIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 53
MIDDLE EAST: NANOSTRUCTURED LIPID CARRIERS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 54
OTHER LNP TYPES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 55
NORTH AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 56
EUROPE: OTHER LNP TYPES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 57
ASIA PACIFIC: OTHER LNP TYPES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 58
LATIN AMERICA: OTHER LNP TYPES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 59
MIDDLE EAST: OTHER LNP TYPES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 60
LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 61
LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2023–2031 (USD MILLION)
TABLE 62
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 63
EUROPE: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 64
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 65
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR SIRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 66
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR SIRNA, BY REGION, 2023–2031 (USD MILLION)
TABLE 67
LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2023–2031 (USD MILLION)
TABLE 68
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 69
EUROPE: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 70
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 71
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR MRNA, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 72
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR MRNA, BY REGION, 2023–2031 (USD MILLION)
TABLE 73
LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2023–2031 (USD MILLION)
TABLE 74
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 75
EUROPE: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 76
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 77
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 78
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER MOLECULES, BY REGION, 2023–2031 (USD MILLION)
TABLE 79
LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 80
LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 81
LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 82
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 83
EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 84
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 85
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 86
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 87
LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2023–2031 (USD MILLION)
TABLE 88
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 89
EUROPE: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 90
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 91
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 92
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR POLYNEUROPATHY, BY REGION, 2023–2031 (USD MILLION)
TABLE 93
LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 94
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 95
EUROPE: LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 96
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 97
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 98
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER COMMERCIAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 99
LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 100
LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 101
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 102
EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 103
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 104
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 105
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 106
LNP RAW MATERIALS MARKET FOR `COVID-19, BY REGION, 2023–2031 (USD MILLION)
TABLE 107
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19 (CLINICAL APPLICATIONS), BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 108
EUROPE: LNP RAW MATERIALS MARKET FOR COVID-19, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 109
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COVID-19, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 110
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COVID-19, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 111
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COVID-19, BY REGION, 2023–2031 (USD MILLION)
TABLE 112
LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2023–2031 (USD MILLION)
TABLE 113
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 114
EUROPE: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 115
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 116
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CANCER, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 117
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CANCER, BY REGION, 2023–2031 (USD MILLION)
TABLE 118
LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 119
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 120
EUROPE: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 121
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 122
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 123
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR OTHER DISEASES, BY REGION, 2023–2031 (USD MILLION)
TABLE 124
LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 125
LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
TABLE 126
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 127
EUROPE: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 128
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 129
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 130
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
TABLE 131
LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
TABLE 132
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 133
EUROPE: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 134
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 135
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 136
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
TABLE 137
LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2023–2031 (USD MILLION)
TABLE 138
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 139
EUROPE: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 140
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 141
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 142
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CDMOS, BY REGION, 2023–2031 (USD MILLION)
TABLE 143
LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 144
FORMULATION DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 145
MANUFACTURING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 146
OTHER SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 147
LNP SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 148
LNP SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
TABLE 149
LNP SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
TABLE 150
LNP RAW MATERIALS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 151
LNP SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 152
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 153
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 154
NORTH AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 155
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 156
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 157
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 158
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 159
NORTH AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 160
NORTH AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 161
NORTH AMERICA: LNP SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 162
US: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 163
US: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 164
US: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 165
US: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 166
US: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 167
US: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 168
US: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 169
CANADA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 170
CANADA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 171
CANADA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 172
CANADA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 173
CANADA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 174
CANADA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 175
CANADA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 176
EUROPE: LNP RAW MATERIALS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 177
EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 178
EUROPE: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 179
EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 180
EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 181
EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 182
EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 183
EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 184
EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 185
EUROPE: LNP SERVICES MARKET BY END USER, 2023–2031 (USD MILLION)
TABLE 186
GERMANY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 187
GERMANY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 188
GERMANY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 189
GERMANY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 190
GERMANY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 191
GERMANY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 192
GERMANY: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 193
UK: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 194
UK: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 195
UK: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 196
UK: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 197
UK: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 198
UK: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 199
UK: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 200
FRANCE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 201
FRANCE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 202
FRANCE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 203
FRANCE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 204
FRANCE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 205
FRANCE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 206
FRANCE: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 207
ITALY: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 208
ITALY: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 209
ITALY: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 210
ITALY: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 211
ITALY: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 212
ITALY: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 213
ITALY: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 214
SPAIN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 215
SPAIN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 216
SPAIN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 217
SPAIN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 218
SPAIN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 219
SPAIN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 220
SPAIN: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 221
REST OF EUROPE: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 222
REST OF EUROPE: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 223
REST OF EUROPE: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 224
REST OF EUROPE: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 225
REST OF EUROPE: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 226
REST OF EUROPE: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 227
REST OF EUROPE: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 228
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 229
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 230
ASIA PACIFIC: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 231
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 232
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 233
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 234
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 235
ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 236
ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 237
ASIA PACIFIC: LNP SERVICES MARKET BY END USER, 2023–2031 (USD MILLION)
TABLE 238
CHINA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 239
CHINA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 240
CHINA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 241
CHINA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 242
CHINA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 243
CHINA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 244
CHINA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 245
JAPAN: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 246
JAPAN: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 247
JAPAN: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 248
JAPAN: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 249
JAPAN: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 250
JAPAN: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 251
JAPAN: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 252
INDIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 253
INDIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 254
INDIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 255
INDIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 256
INDIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 257
INDIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 258
INDIA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 259
SOUTH KOREA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 260
SOUTH KOREA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 261
SOUTH KOREA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 262
SOUTH KOREA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 263
SOUTH KOREA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 264
SOUTH KOREA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 265
SOUTH KOREA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 266
AUSTRALIA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 267
AUSTRALIA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 268
AUSTRALIA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 269
AUSTRALIA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 270
AUSTRALIA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 271
AUSTRALIA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 272
AUSTRALIA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 273
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 274
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 275
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 276
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 277
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 278
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 279
REST OF ASIA PACIFIC: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 280
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 281
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 282
LATIN AMERICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 283
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 284
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 285
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 286
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 287
LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 288
LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 289
LATIN AMERICA: LNP SERVICES MARKET BY END USER, 2023–2031 (USD MILLION)
TABLE 290
BRAZIL: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 291
BRAZIL: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 292
BRAZIL: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 293
BRAZIL: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 294
BRAZIL: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 295
BRAZIL: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 296
BRAZIL: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 297
MEXICO: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 298
MEXICO: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 299
MEXICO: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 300
MEXICO: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 301
MEXICO: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 302
MEXICO: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 303
MEXICO: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 304
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 305
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 306
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 307
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 308
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 309
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 310
REST OF LATIN AMERICA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 311
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 312
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 313
MIDDLE EAST: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 314
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 315
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 316
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 317
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 318
MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 319
MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 320
MIDDLE EAST: LNP SERVICES MARKET BY END USER, 2023–2031 (USD MILLION)
TABLE 321
GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 322
GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 323
GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 324
GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 325
GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 326
GCC COUNTRIES: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 327
GCC COUNTRIES: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 328
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 329
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 330
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 331
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 332
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 333
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 334
REST OF MIDDLE EAST: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 335
AFRICA: LNP RAW MATERIALS MARKET, BY PRODUCT, 2023–2031 (USD MILLION)
TABLE 336
AFRICA: LNP SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 337
AFRICA: LNP RAW MATERIALS MARKET, BY LNP TYPE, 2023–2031 (USD MILLION)
TABLE 338
AFRICA: LNP RAW MATERIALS MARKET, BY MOLECULE TYPE, 2023–2031 (USD MILLION)
TABLE 339
AFRICA: LNP RAW MATERIALS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 340
AFRICA: LNP RAW MATERIALS MARKET FOR COMMERCIAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 341
AFRICA: LNP RAW MATERIALS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2031 (USD MILLION)
TABLE 342
AFRICA: LNP RAW MATERIALS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 343
AFRICA: LNP SERVICES MARKET BY END USER, 2023–2031 (USD MILLION)
TABLE 344
OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, 2023–2026
TABLE 345
LNP RAW MATERIALS MARKET: DEGREE OF COMPETITION
TABLE 346
LNP SERVICES MARKET: TOP SERVICE PROVIDERS (2025)
TABLE 347
LIPID NANOPARTICLES MARKET: REGION FOOTPRINT
TABLE 348
LIPID NANOPARTICLES MARKET: PRODUCT FOOTPRINT
TABLE 349
LIPID NANOPARTICLES MARKET: APPLICATION FOOTPRINT
TABLE 350
LIPID NANOPARTICLES MARKET: SERVICE FOOTPRINT
TABLE 351
LIPID NANOPARTICLES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 352
LIPID NANOPARTICLES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 353
LIPID NANOPARTICLES MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
TABLE 354
LIPID NANOPARTICLES MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 355
LIPID NANOPARTICLES MARKET: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 356
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY OVERVIEW
TABLE 357
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): PRODUCTS/ SERVICES OFFERED
TABLE 358
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 359
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 360
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 361
AVANTI POLAR LIPIDS: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 362
MERCK KGAA: COMPANY OVERVIEW
TABLE 363
MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 364
MERCK KGAA: SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 365
MERCK KGAA: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 366
EVONIK INDUSTRIES AG: COMPANY OVERVIEW
TABLE 367
EVONIK INDUSTRIES AG: PRODUCTS/SERVICES OFFERED
TABLE 368
EVONIK INDUSTRIES AG: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 369
EVONIK INDUSTRIES AG: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 370
NIPPON FINE CHEMICAL CO., LTD.: COMPANY OVERVIEW
TABLE 371
NIPPON FINE CHEMICAL CO., LTD.: PRODUCTS/SERVICES OFFERED
TABLE 372
NOF CORPORATION: COMPANY OVERVIEW
TABLE 373
NOF CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 374
NOF CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 375
NOF CORPORATION: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 376
FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY OVERVIEW
TABLE 377
FUJIFILM PHARMACEUTICALS U.S.A., INC.: PRODUCTS/SERVICES OFFERED
TABLE 378
FUJIFILM PHARMACEUTICALS U.S.A., INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 379
FUJIFILM PHARMACEUTICALS U.S.A., INC.: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 380
PRECISION NANOSYSTEMS: COMPANY OVERVIEW
TABLE 381
PRECISION NANOSYSTEMS: PRODUCTS/SERVICES OFFERED
TABLE 382
PRECISION NANOSYSTEMS: SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 383
RECIPHARM AB: COMPANY OVERVIEW
TABLE 384
RECIPHARM AB: PRODUCTS/SERVICES OFFERED
TABLE 385
RECIPHARM AB: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 386
RECIPHARM AB: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 387
EMERGENT: COMPANY OVERVIEW
TABLE 388
EMERGENT: PRODUCTS/SERVICES OFFERED
TABLE 389
EUROAPI: COMPANY OVERVIEW
TABLE 390
EUROAPI: PRODUCTS/SERVICES OFFERED
TABLE 391
CAYMAN CHEMICAL: COMPANY OVERVIEW
TABLE 392
CAYMAN CHEMICAL: PRODUCTS/SERVICES OFFERED
TABLE 393
CAYMAN CHEMICAL: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 394
CAYMAN CHEMICAL: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 395
CORDENPHARMA: COMPANY OVERVIEW
TABLE 396
CORDENPHARMA: PRODUCTS/SERVICES OFFERED
TABLE 397
CORDENPHARMA: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 398
CORDENPHARMA: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 399
CORDENPHARMA: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 400
GATTEFOSSÉ: COMPANY OVERVIEW
TABLE 401
GATTEFOSSÉ: PRODUCTS/SERVICES OFFERED
TABLE 402
ACUITAS THERAPEUTICS: COMPANY OVERVIEW
TABLE 403
ACUITAS THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 404
ACUITAS THERAPEUTICS: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 405
IOI OLEO GMBH: COMPANY OVERVIEW
TABLE 406
IOI OLEO GMBH: PRODUCTS/SERVICES OFFERED
TABLE 407
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
FIGURE 2
GLOBAL LNP RAW MATERIALS MARKET, 2023–2031
FIGURE 3
GLOBAL LNP SERVICES MARKET, 2023–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LNP RAW MATERIALS MARKET, 2023–2026
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LNP SERVICES MARKET, 2023–2026
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF LNP RAW MATERIALS & SERVICES MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN LNP RAW MATERIALS & SERVICES MARKET, 2026–2031
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN LNP RAW MATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9
ASIAC PACIFIC TO REGISTER HIGHEST CAGR IN LNP SERVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10
INCREASING USE OF LIPID NANOPARTICLES IN RNA-BASED THERAPIES TO PROPEL LNP RAW MATERIALS MARKET
FIGURE 11
US AND IONIZABLE LIPIDS ACCOUNTED FOR LARGEST MARKET SHARES IN NORTH AMERICA IN 2025
FIGURE 12
ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 13
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 14
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 15
LIPID NANOPARTICLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16
LIPID NANOPARTICLES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17
LNP RAW MATERIALS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
LNP SERVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 19
LIPID NANOPARTICLES MARKET ECOSYSTEM
FIGURE 20
REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN THE LIPID NANOPARTICLES MARKET
FIGURE 21
TOP APPLICANTS & OWNERS (COMPANIES) FOR LIPID NANOPARTICLE PATENTS, 2015–DECEMBER 2025
FIGURE 22
IMPACT OF AI/GEN AI ON LIPID NANOPARTICLES MARKET
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 24
KEY BUYING CRITERIA FOR LIPID NANOPARTICLE RAW MATERIALS, BY END USER
FIGURE 25
KEY BUYING CRITERIA FOR LIPID NANOPARTICLE SERVICES, BY END USER
FIGURE 26
NORTH AMERICA: LNP RAW MATERIALS MARKET SNAPSHOT
FIGURE 27
ASIA PACIFIC: LNP RAW MATERIALS MARKET SNAPSHOT
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET, 2019–2025 (USD MILLION)
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN LNP RAW MATERIALS MARKET (2025)
FIGURE 30
LIPID NANOPARTICLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
LIPID NANOPARTICLES MARKET: COMPANY FOOTPRINT
FIGURE 32
LIPID NANOPARTICLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
EV/EBITDA OF KEY VENDORS
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35
LIPID NANOPARTICLES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 36
AVANTI POLAR LIPIDS (CRODA INTERNATIONAL PLC): COMPANY SNAPSHOT (2025)
FIGURE 37
MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 38
EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2025)
FIGURE 39
NIPPON FINE CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 40
NOF CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41
FUJIFILM PHARMACEUTICALS U.S.A., INC.: COMPANY SNAPSHOT (2025)
FIGURE 42
RECIPHARM AB: COMPANY SNAPSHOT (2025)
FIGURE 43
EMERGENT: COMPANY SNAPSHOT (2025)
FIGURE 44
EUROAPI: COMPANY SNAPSHOT (2025)
FIGURE 45
IOI OLEO GMBH: COMPANY SNAPSHOT (2025)
FIGURE 46
RESEARCH DESIGN
FIGURE 47
LNP RAW MATERIALS & SERVICES MARKET: BREAKDOWN OF PRIMARIES
FIGURE 48
LNP RAW MATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 49
LNP SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
FIGURE 50
MARKET SIZE ESTIMATION (RAW MATERIALS): APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
FIGURE 51
MARKET SIZE ESTIMATION (SERVICES): APPROACH
FIGURE 52
ILLUSTRATIVE EXAMPLE OF NOF CORPORATION: REVENUE SHARE ANALYSIS (2025)
FIGURE 53
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 54
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 55
LNP RAW MATERIALS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 56
LNP SERVICES MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 57
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Lipid Nanoparticles Market